May 16, 2024 – Page 13 – Goldea Capital

Vallourec First Quarter 2024 Results

Written by Customer Service on May 16, 2024. Posted in Earnings Releases And Operating Results.

Meudon (France), May 16th, 2024 Vallourec, a world leader in premium tubular solutions, announces today its results for the first quarter 2024. The Board of Directors of Vallourec SA, meeting on May 15th 2024, approved the Group’s first quarter 2024 Consolidated Financial Statements. First Quarter 2024 Results Cash generation capability of New Vallourec on display with sixth straight quarter of deleveraging International OCTG pricing remains strong due to robust demand pipeline across multiple geographic regions Market demand remains stable in the US; industry inventories have normalized Expect to reduce net debt further in the second quarter Target initiation of capital returns to shareholders in 2025 at the latesta HIGHLIGHTS First Quarter 2024 Results Effects of New Vallourec plan and Value over Volume strategy on display: Tubes...

TCM Group A/S: Interim report Q1 2024

Written by Customer Service on May 16, 2024. Posted in Earnings Releases And Operating Results.

COMPANY ANNOUNCEMENT No. 191/2024 Tvis, 16 May 2024 Interim report Q1 2024 (January 1 – March 31) (All figures in brackets refer to the corresponding period in 2023 – AUBO Production A/S is incl.in the figures as from 3 July 2023) Continued B2C recovery in Q1 under challenging market conditions. CEO Torben Paulin:“Sales in the quarter developed in line with our expectations, with the order-intake in the B2C market in Denmark continuing to improve across most of our brands. B2B sales, as expected, continued to contract primarily within project sales. Revenue in Q1, was DKK 293 million compared to DKK 264 million in Q1 last year. Underlying organic like-for-like sales declined by 12% in the quarter. Sales in Norway, which accounted for 20% of the Groups revenue, were negatively impacted by the slowdown in the B2B market which...

Multitude SE with continued strong growth at the start of 2024: EBIT increases by 31 percent to EUR 11.6 million

Written by Customer Service on May 16, 2024. Posted in Earnings Releases And Operating Results.

Multitude SE with continued strong growth at the start of 2024: EBIT increases by 31 percent to EUR 11.6 million Key takeaways: Significant EBIT growth of 31.0% to EUR 11.6 million compared to the same period of the previous year Revenue increases by 18.3% to EUR 64.2 million Consolidated net profit increases by 13.0% to EUR 2.6 million, EPS by 48.8% to EUR 0.07 Multitude SE strengthens market position with the acquisition of Omniveta’s business On track to achieve EBIT forecast of EUR 67.5 million in 2024 Helsinki, 16 May 2024 – Multitude SE, a listed European FinTech company, offering digital lending and online banking services to consumers, small and medium-sized businesses, and other FinTechs (ISIN: FI4000106299, WKN: A1W9NS) (“Multitude”, “Company” or “Group”) has published its quarterly figures for Q1 2024, which show...

High Arctic Announces 2024 First Quarter Results

Written by Customer Service on May 16, 2024. Posted in Earnings Releases And Operating Results.

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW CALGARY, Alberta, May 15, 2024 (GLOBE NEWSWIRE) — High Arctic Energy Services Inc. (TSX: HWO) (the “Corporation” or “High Arctic”) released its’ first quarter financial and operating results. The unaudited consolidated financial statements, management discussion & analysis (“MD&A”), for the quarter ended March 31, 2024 will be available on SEDAR+ at www.sedarplus.ca, and on High Arctic’s website at www.haes.ca. All amounts are denominated in Canadian dollars (“CAD”), unless otherwise indicated. Intention to Return Capital and ReorganizeOn May 11, 2024 the Corporation announced the Annual General and Special Meeting of Shareholders to be...

Vastned Retail and Vastned Belgium announce intention to merge

Written by Customer Service on May 16, 2024. Posted in Mergers And Acquisitions.

• Vastned Retail and Vastned Belgium intend to merge Vastned Retail into Vastned Belgium, to be named “Vastned” • The Merger aims to generate value for Vastned and its stakeholders, including: o Simplification of organizational and governance structure, while continuing current successful strategy; o Expected future recurring annual operational cost synergies of approx. EUR 2.0 – 2.5 million; o Optimized debt financing; o Increased free float and liquidity; o One single listed platform under Belgium’s REIT regime; o More portfolio diversification; o Future ability to pursue accretive growth • One listed organization with trading on Euronext Brussels and Euronext Amsterdam, with an expected increase in free float and liquidity for shareholders and a more interesting profile for equity analyst coverage • Vastned...

Zealand Pharma Announces Financial Results for the First Quarter of 2024

Written by Customer Service on May 16, 2024. Posted in Earnings Releases And Operating Results.

Company announcement – No. 26 / 2024 Zealand Pharma Announces Financial Results for the First Quarter of 2024 Strong performance in the first quarter of 2024 paving the way for important data read-outs across differentiated obesity assets in the second quarter. Strong topline results announced in Boehringer Ingelheim Phase 2 clinical trial for survodutide in MASH PDUFA date for glepaglutide in SBS set by US FDA for December 22, 2024 PDUFA date for dasiglucagon in CHI for up to three weeks of dosing (Part 1 of NDA) set by US FDA for October 8, 2024 Cash runway extended into 2027 through private placement of shares to institutional investors in January 2024 for gross proceeds of DKK 1.45 billion Copenhagen, Denmark, May 16, 2024 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery...

VEON 1Q24 Trading Update: Accelerating USD Growth, Strong Operational Execution

Written by Customer Service on May 16, 2024. Posted in Earnings Releases And Operating Results.

VEON 1Q24 Trading Update: Accelerating USD Growth, Strong Operational Execution Amsterdam, 16 May 2024 07:00AM CEST – VEON Q1 2024 Highlights Q1 revenue of USD 942 million, +6.6% YoY (+11.6% YoY in local currency) and EBITDA of USD 386 million, +0.2% YoY (+5.1% YoY in local currency) Q1 capex of USD 125 million, +38.6% YoY, with LTM capex intensity of 18.3% Total cash and cash equivalents of USD 632 million, with USD 261 million at HQ; and gross debt at USD 3.7 billion (decreased by USD 2.0 billion YoY), with net debt excluding lease liabilities at USD 2.0 billion; VEON repaid its Revolving Credit Facility Maintaining FY 2024 revenue growth guidance in local currency of 16-18%, EBITDA growth guidance in local currency of 18-20%, and capex intensity of 18-19% VEON management increases share ownership; announces its 2024 Annual General...

Consolidated interim report 1 January – 31 March 2024

Written by Customer Service on May 16, 2024. Posted in Earnings Releases And Operating Results.

Consolidated interim report 1 January – 31 March 2024 Company announcement no. 17 Date: 16 May 2024 Key points from Q1-24 report (period 1 January – 31 March 2024) On 16 May 2024, the Board of Directors and the Executive Management of Pharma Equity Group A/S (“PEG”, “the Company” or “the Group”) considered and approved the interim report of the Group for the period 1 January – 31 March 2024 (“Q1 2024 Report”). The report has not been audited or reviewed. Clinical results Shortly after the end of Q1, the Company’s subsidiary, Reponex Pharmaceuticals A/S (Reponex), was able to report very positive final results from Reponex’ clinical phase 2 proof-of-concept trial of the drug candidate RNX-051, the MEFO study, based on the high-level summary received from Reponex’ clinical site. Reference is made to company announcement...

Vastned Belgium: Application of article 7:97 BCAC by the Board of Directors of Vastned Belgium

Written by Customer Service on May 16, 2024. Posted in Mergers And Acquisitions.

The board of directors of Vastned Belgium NV (Euronext: VASTB, “Vastned Belgium” or the “Company”) has requested the committee of independent directors of the Company (the “Committee”) to issue an opinion in application of article 7:97 of the Belgian Companies and Associations Code (the “BCAC”) on the conclusion of an agreement entitled “Merger Protocol” (the “Merger Protocol”) between the Company and Vastned Retail NV, a listed public limited liability company incorporated under Dutch law, having its corporate seat in Amsterdam, the Netherlands, and its principal place of business at Mercuriusplein 11, 2132 HA Hoofddorp, the Netherlands and registered in the trade register of the Dutch Chamber of Commerce (Kamer van Koophandel) under number 24262564 (“Vastned Retail” and together with the Company, the “Parties” and, together with their...

Wilhelmina International, Inc. Reports Results for First Quarter 2024

Written by Customer Service on May 16, 2024. Posted in Earnings Releases And Operating Results.

(in thousands) Q1 2024 Q1 2023 YOYChange Total Revenues $ 4,171 $ 4,484 (7.0 %) Operating Income 73 229 (68.1 %) Income Before Provision for Taxes 149 210 (29.0 %) Net Income 91 159 (42.8 %) Gross Billings* 15,824 17,587 (10.0 %) EBITDA* 110 262 (58.0 %) Adjusted EBITDA* 128 304 (57.9 %) Pre-Corporate EBITDA* 381 548 (30.5 %) * Non-GAAP measures referenced are detailed in the disclosures at the end of this release. DALLAS, May 16, 2024 (GLOBE NEWSWIRE) — Wilhelmina International, Inc. (Nasdaq:WHLM) (“Wilhelmina” or the “Company”) today reported revenues of $4.2 million and net income of $0.1 million for the three months ended March 31, 2024, compared to revenues of $4.5 million and net income of $0.2 million for the three months ended March 31, 2023....

Day: May 16, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice